Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Recruiting now · Not applicable

Conditions studied: Thyroid Eye Disease

In brief

FAPI PET has been developed as a promising approach for the evaluation of fibroinflammatory, such as in inflammatory bowel disease. This prospective study aims to explore the value of 18F-AlF-FAPI PET/CT in assessing the activity of Thyroid Eye Disease (TED) and investigate whether FAPI PET/CT may be superior to 99mTc-DTPA SPECT/CT for the diagnosis, therapy response assessment, and follow-up of TED.

Key facts

Study ID

NCT06359795

Run by

Peking University Third Hospital

People needed

50

Starts

2023-12-15

Expected to finish

2027-12-31

Last updated by the study team

2024-04-11

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 18 years;
• Patients diagnosed with TED;
• Complete understanding and voluntary participation in this study, with the signing of an informed consent form.

You may not qualify if…

• Severe liver or kidney dysfunction;
• Inability to maintain a supine position for 5 minutes to cooperate with the examination;
• Suffering from claustrophobia or other psychiatric disorders;
• Patients planning pregnancy or in the prenatal or lactation period;
• Other conditions deemed unsuitable for participation in the trial by the investigator.

Where it is running

• Dept. of Nuclear Medicine, Peking University Third Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.